The Food and Drug Administration is making as much as $1 million in grant funding available for mining a large database of electronic health records to conduct postmarket surveillance of drug safety.
The FDA’s Center for Drug Evaluation and Research (CDER) will award a one-year grant by summer to a single bidder to develop “new analytic methodologies” to look for signs of pharmaceutical-related safety problems in the Mini-Sentinel Distributed Database, an FDA-funded pilot with access to 178 million medical records.